{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:39:52Z","timestamp":1791855592604,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ahj.2020.10.001","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T01:11:57Z","timestamp":1602292317000},"page":"128-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial"],"prefix":"10.1016","volume":"231","author":[{"given":"Helio P.","family":"Guimar\u00e3es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro G.M.","family":"de Barros e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idelzuita L.","family":"Liporace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roney O.","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio","family":"Tarasoutchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Paix\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrado R.","family":"Hoffmann-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Patriota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago L.L.","family":"Leiria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lamprea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton B.","family":"Precoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A.","family":"Atik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio S.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio R.","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo O.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adail P.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre C.","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o D.","family":"de Souza Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A.M.S.","family":"Figueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roque A.","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdir A.","family":"Mois\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezar E.","family":"Mesas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto V.","family":"Ardito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo S.A.","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.M.O.","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime G.A.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.B.","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"D'Oliveira Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia","family":"Laranjeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato H.","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana R.Y.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna S.","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane B.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose F.K.","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco H.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraim M.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos C.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao F.M.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Pavanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre B.","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio","family":"Berwanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9540","key":"10.1016\/j.ahj.2020.10.001_bb0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ahj.2020.10.001_bb0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"6Supl.2","key":"10.1016\/j.ahj.2020.10.001_bb0015","first-page":"1","article-title":"Atualiza\u00e7\u00e3o das Diretrizes Brasileiras de Valvopatias: Abordagem das Les\u00f5es Anatomicamente Importantes","volume":"109","author":"Tarasoutchi","year":"2017","journal-title":"Arq Bras Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2020.10.001_bb0020","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/hrt.2004.042762","article-title":"Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents","volume":"91","author":"Meira","year":"2005","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ahj.2020.10.001_bb0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC Focused Update of the 2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2020.10.001_bb0030","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0003-4975(96)82420-9","article-title":"Mechanical valves","volume":"62","author":"David","year":"1996","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.ahj.2020.10.001_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1054-8807(03)00002-4","article-title":"Biological replacement heart valves","volume":"12","author":"Butany","year":"2003","journal-title":"Identification and evaluation Cardiovasc Pathol"},{"key":"10.1016\/j.ahj.2020.10.001_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ncpcardio0112","article-title":"Will heart valve tissue engineering change the world?","volume":"2","author":"Yacoub","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"9689","key":"10.1016\/j.ahj.2020.10.001_bb0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(09)60780-7","article-title":"Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends","volume":"374","author":"Sun","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ahj.2020.10.001_bb0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0003-4975(10)60033-1","article-title":"Thromboembolism in patients with aortic porcine bioprostheses","volume":"40","author":"David","year":"1985","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.ahj.2020.10.001_bb0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1510\/icvts.2006.143099","article-title":"Is short-term anticoagulation necessary after mitral valve repair?","volume":"5","author":"Asopa","year":"2006","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.ahj.2020.10.001_bb0060","article-title":"Antiplatelet and anticoagulation for patients with prosthetic heart valves","volume":"7","author":"Massel","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ahj.2020.10.001_bb0065","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","article-title":"High risk of thromboemboli early after bioprosthetic cardiac valve replacement","volume":"25","author":"Heras","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.10.001_bb0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0002-9149(97)89145-X","article-title":"Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease","volume":"77","author":"Diker","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2020.10.001_bb0075","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7326\/0003-4819-52-4-741","article-title":"The course of mitral stenosis without surgery: ten- and twenty-year perspectives","volume":"52","author":"Rowe","year":"1960","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ahj.2020.10.001_bb0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0735-1097(02)01922-8","article-title":"Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome","volume":"40","author":"Grigioni","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"3 Pt 1","key":"10.1016\/j.ahj.2020.10.001_bb0085","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0002-8703(95)90365-8","article-title":"Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a metaanalysis","volume":"130","author":"Cappelleri","year":"1995","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2020.10.001_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","article-title":"Optimal oral anticoagulant therapy in patients with mechanical heart valves","volume":"333","author":"Cannegieter","year":"1995","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.ahj.2020.10.001_bb0095","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/euhj.2002.3320","article-title":"Recommendations on the management of the asymptomatic patient with valvular heart disease","volume":"23","author":"Iung","year":"2002","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2020.10.001_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1067\/mhj.2001.116331","article-title":"Antithrombotic therapy after prosthetic cardiac valve implantation: potential novel antithrombotic therapies","volume":"142","author":"Berkowitz","year":"2001","journal-title":"Am Heart J"},{"issue":"1 Suppl","key":"10.1016\/j.ahj.2020.10.001_bb0105","doi-asserted-by":"crossref","first-page":"220S","DOI":"10.1378\/chest.119.1_suppl.220S","article-title":"Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves","volume":"119","author":"Stein","year":"2001","journal-title":"Chest"},{"issue":"8597","key":"10.1016\/j.ahj.2020.10.001_bb0110","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(88)92070-3","article-title":"Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement","volume":"1","author":"Turpie","year":"1988","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.ahj.2020.10.001_bb0115","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2020.10.001_bb0120","doi-asserted-by":"crossref","first-page":"e576S","DOI":"10.1378\/chest.11-2305","article-title":"Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Whitlock","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ahj.2020.10.001_bb0125","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2020.10.001_bb0130","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-5223(97)70264-2","article-title":"Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves","volume":"113","author":"Meschengieser","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2020.10.001_bb0135","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2012.05.029","article-title":"Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database","volume":"60","author":"Brennan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.10.001_bb0140","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.jacc.2015.09.022","article-title":"Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors","volume":"66","author":"Egbe","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.10.001_bb0145","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.2012.54506","article-title":"Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding","volume":"308","author":"M\u00e9rie","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2020.10.001_bb0150","unstructured":"Hong GR. Edoxaban versus warfarin after surgical bioprosthetic valve implantation or valve repair. Presented on: March 30, 2020. ACC 2020.acess in: https:\/\/accscientificsession.acc.org\/."},{"issue":"23","key":"10.1016\/j.ahj.2020.10.001_bb0155","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.ahj.2020.10.001_bb0160","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2020.10.001_bb0165","doi-asserted-by":"crossref","first-page":"A17277","DOI":"10.1161\/circ.132.suppl_3.17277","article-title":"Apixaban use in patients with atrial fibrillation with bioprosthetic valves: insights from ARISTOTLE","volume":"132","author":"Pokorney","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2020.10.001_bb0170","first-page":"1273","article-title":"On behalf of the ENGAGE AF-TIMI 48 Investigators","volume":"135","author":"Carnicelli","year":"2017","journal-title":"Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2020.10.001_bb0175","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00228-005-0043-5","article-title":"Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939\u2014an oral, direct Factor Xa inhibitor\u2014after multiple dosing in healthy male subjects","volume":"61","author":"Kubitza","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.ahj.2020.10.001_bb0180","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/0091270006292127","article-title":"Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban\u2014an oral, direct factor Xa inhibitor\u2014are not affected by aspirin","volume":"46","author":"Kubitza","year":"2006","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.ahj.2020.10.001_bb0185","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ahj.2020.10.001_bb0190","doi-asserted-by":"crossref","first-page":"e002776","DOI":"10.1161\/JAHA.115.002776","article-title":"Use of direct oral anticoagulants in patients with atrial fibrillation and valvular heart lesions","volume":"5","author":"Di Biase","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2020.10.001_bb0195","doi-asserted-by":"crossref","unstructured":"Zhao l et. al. On the restricted mean survival time curve in survival analysis, biometrics, 2016, 72:215\u2013221.","DOI":"10.1111\/biom.12384"},{"issue":"2","key":"10.1016\/j.ahj.2020.10.001_bb0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/M14-1741","article-title":"Alternatives to hazard ratios for comparing the efficacy or safety of therapies in noninferiority studies","volume":"163","author":"Uno","year":"2015","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ahj.2020.10.001_bb0205","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jamacardio.2017.2922","article-title":"Restricted mean survival time as a measure to interpret clinical trial results","volume":"2","author":"Kim","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"17","key":"10.1016\/j.ahj.2020.10.001_bb0210","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/CIRCULATIONAHA.119.040680","article-title":"Using the restricted mean survival time difference as an alternative to the hazard ratio for analyzing clinical cardiovascular studies","volume":"140","author":"McCaw","year":"2019","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ahj.2020.10.001_bb0215","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1200\/JCO.2014.55.2208","article-title":"Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis","volume":"32","author":"Uno","year":"2014","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ahj.2020.10.001_bb0220","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.014807","article-title":"Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial","volume":"132","author":"Avezum","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ahj.2020.10.001_bb0225","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ahj.2020.10.001_bb0230","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2020.10.001_bb0235","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0037-1615261","article-title":"D' Onofrio A Nonvitamin K antagonist oral anticoagulants use in patients with atrial fibrillation and bioprosthetic heart valves\/prior surgical valve repair: a multicenter clinical practice experience","volume":"44","author":"Russo","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ahj.2020.10.001_bb0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2019.06.014","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study","volume":"299","author":"Yang","year":"2020","journal-title":"Int J Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320302775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320302775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:06:02Z","timestamp":1757570762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870320302775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":48,"alternative-id":["S0002870320302775"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2020.10.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2020.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}